1. Hong Kong Stocks

  2. •

    Process industries

  3. •

    Chemicals: major diversified
Wai Chun Bio-Technology Ltd.

Wai Chun Bio-Technology Ltd.

HHKEX:660
0.41
HKD
-0.02
(-5.81%)
33.55MMarket Cap
Wai Chun Bio-Technology Ltd.
HKEX:660
(Hong Kong Exchange)

Recent

price

0.41

P/E

ratio

- -

div

yld

- -

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
HKD
1.87
2.34
2.46
2.42
2.5
2.36
2.86
3.14
2.9
3.49
3.42
2.96
- -
4.58
2.16
2.17
- -
Revenue per Share
0.13
-0.02
-0.22
-0.2
-0.1
-0.12
-0.24
-0.11
-0.32
-0.02
-0.05
-0.1
- -
-0.09
-0.26
-0.08
- -
Basic EPS, GAAP
-0.26
-0.32
-0.75
0.83
-0.14
-0.06
-0.13
- -
-0.08
0.01
-0.08
-0.06
- -
0.12
0.07
-0.14
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.18
0.16
-0.06
0.05
-0.05
-0.16
-0.11
-0.2
-0.29
-0.31
-0.23
-0.32
-0.22
-0.2
-0.46
-0.51
-0.36
Book Value per Share
0.18
0.16
-0.06
0.05
-0.05
-0.16
-0.29
-0.4
-0.47
-0.48
-0.41
-0.5
-0.4
-0.36
-0.61
-0.65
-0.36
Tangible Book Value per Share
152
155
155
155
158
160
163
163
166
166
166
167
168
169
171
173
178
Basic Weighted Avg Shares
284
362
381
374
394
377
465
512
481
579
568
495
- -
774
370
377
- -
Sales/Revenue/Turnover
-4.59
6.11
-5.26
-6.52
-4.18
-4.67
-7.99
-3.38
-11.23
2.75
2.01
0.37
- -
1.88
0.39
0.29
- -
Operating Margin (%)
2
1
3
3
4
3
4
5
4
5
6
- -
- -
14
11
13
- -
Depreciation Expense
20
-4
-34
-31
-16
-20
-39
-17
-54
-3
-8
-17
- -
-15
-44
-15
- -
Net Income, GAAP
3.68
42.05
- -
- -
- -
- -
- -
- -
- -
0.83
38.24
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
7.15
-1.03
-8.97
-8.24
-4.03
-5.2
-8.43
-3.4
-11.15
-0.55
-1.44
-3.44
- -
-1.99
-11.95
-3.88
- -
Profit Margin (%)
23
20
11
-29
-50
-61
-63
-82
-84
-72
-60
-63
-25
-30
-139
-171
-61
Working Capital
- -
- -
- -
12
18
27
15
25
34
44
51
54
66
71
11
- -
78
LT Debt
45
64
21
32
8
-19
-12
-32
-45
-37
-13
-24
6
11
-55
-63
-35
Total Equity
-27.53
8.02
- -
- -
- -
- -
- -
- -
- -
23.57
6.65
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
46.75
-10.17
- -
- -
- -
- -
- -
- -
- -
-16.45
-13.82
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
-14.39
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

HKD

•

in mil. unless spec.
Dec'25
Jun'25
Dec'26
ST Debt
135
95
64
LT Borrowings
12
- -
78
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
171
178
178
Market Capitalization
11
25
34

Working Capital

HKD

•

in mil. unless spec.
Dec'25
Jun'25
Dec'26
Total Current Assets
93
107
121
Cash, Cash Equivalents & STI
2
7
6
Accounts Receivable, Net
23
29
50
Inventories
30
57
48
Total Current Liabilities
237
277
183
Payables & Accruals
- -
- -
- -
ST Debt
135
95
64
Deferred Revenue
- -
- -
- -

Growth Rates

HKD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-48.78%
-115.64%
13.42%
Free Cash Flow
- -
- -
-304.14%
Net Income, GAAP
- -
- -
-66.93%
Sales/Revenue/Turnover
- -
- -
1.92%
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
370
2025
- -
- -
377
2026
- -
- -
- -

Semi-annual Earnings Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
-0.26
2025
- -
- -
-0.08
2026
- -
- -
- -

Semi-annual Dividends Per Share

HKD

•

in mil. unless spec.

Year

H1
H2
FY
2024
- -
- -
- -
2025
- -
- -
- -
2026
- -
- -
- -
Similar Companies
Hektas Ticaret T.A.S. (BIST:HEKTS)
AARTI Industries Ltd (NSE:AARTIIND)
Aether Industries Ltd. (NSE:AETHER)
Mitsui & Co.,Ltd (TSE:8031)
Saudi Basic Industries Corp. (TADAWUL:2010)
Raghav Productivity Enhancers Ltd. (NSE:RPEL)
Business
Wai Chun Bio-Technology Limited is a Hong Kong-based investment holding company principally engaged in the manufacture and sale of modified starch and other biochemical products, such as biochemical refined oil products, in the People's Republic of China; it also trades electronic parts, components and electrical appliances, as well as athletic and athlete-style footwear, working shoes, safety shoes, golf shoes, and other functional footwear. Incorporated in 1992 and headquartered at 13/F, Admiralty Centre, Tower II, 18 Harcourt Road, Admiralty, Hong Kong, the company operates production facilities in the PRC serving consumer markets including food processing and industrial applications. Recent developments include a substantial reduction in net loss to HK$14.62 million for the fiscal year ended June 30, 2025, from HK$44.21 million the prior year, driven by lower impairment losses on non-financial assets and revenue growth to HK$377.17 million; a change in head office address announced in early 2025; board changes effective June 5, 2025, including the resignation of a director; an extraordinary general meeting held on September 17, 2025, with a passed resolution; and a revised timetable for capital reorganization and convertible bond alterations, targeting effectiveness by October 28, 2025.